Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)
- 1 January 1999
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 17 (3) , 255-263
- https://doi.org/10.1023/a:1006665616932
Abstract
A long latent period of 20 to 30 years may be involved in the multistep process of carcinogenesis represented by prostatic intraepithelial neoplasia (PIN) in the prostate. It is, therefore, possible...Keywords
This publication has 44 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cellsCancer Letters, 1996
- Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cellsMolecular Carcinogenesis, 1996
- Retinoids and Apoptosis: Implications for Cancer Chemoprevention and TherapyJNCI Journal of the National Cancer Institute, 1995
- Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: Implications for chemopreventionJournal of Cellular Biochemistry, 1995
- Unassembled (soluble) vimentin in human myeloid leukemia cell line HL60European Journal of Haematology, 1994
- N‐(4‐hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC3 cellsThe Prostate, 1994
- Differentiation state and invasiveness of human breast cancer cell linesBreast Cancer Research and Treatment, 1994
- Differential expression of vimentin in rat prostatic tumorsBiochemical and Biophysical Research Communications, 1992
- Prostatic intraepithelial neoplasia (PIN): Morphological clinical significanceThe Prostate, 1992